Business ❯Healthcare

Pharmaceuticals

Drug Development Weight Loss Drugs Clinical Trials Market Competition Drug Pricing Drug Sales Acquisitions Biotechnology Weight Loss Vaccine Development

Walgreens Shareholders Approve $10 Billion Sale to Sycamore Partners

The agreement requires regulatory clearance for its slated third or fourth quarter 2025 closing

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

AMD Shares Surge on Next-Gen MI400 AI Chips and Helios Server Rack

Adar Poonawalla Acquires 50% of Dharma Productions as Johar Retains Creative Control

Faes Farma Finalizes €270 Million Acquisition of Italian Ophthalmology Specialist SIFI

Dr. Reddy’s and Alvotech Partner to Develop Global Keytruda Biosimilar

Zydus Lifesciences to Acquire Agenus’ California Biologics Facilities

Carlyle, TPG and Major Shareholders to Offload Rs3,480 Crore in Block Deals on June 4

Indivior to Abandon London Listing to Focus Solely on Nasdaq

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Sharmin Segal and Aman Mehta Welcome First Child, a Baby Boy

S&P 500 and Nasdaq Log Biggest Monthly Rally Since 2023, But Tariff Risks Persist

Emcure Pharmaceuticals Reports 64% Profit Surge, Shares Hit Upper Circuit

Sun Pharma Shares Drop 5% Following Mixed Q4 FY25 Results

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

Mankind Pharma Posts Profit Decline but Outperforms Estimates with Strong Revenue Growth

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact